Oxcarbazepine was associated with risks of newly developed hypothyroxinaemia and impaired central set point of thyroid homeostasis in schizophrenia patients

@article{Zhai2021OxcarbazepineWA,
  title={Oxcarbazepine was associated with risks of newly developed hypothyroxinaemia and impaired central set point of thyroid homeostasis in schizophrenia patients},
  author={Desheng Zhai and Jinni Chen and Bao-Qiang Guo and Ravi Retnakaran and Songyin Gao and Xiang Yang Zhang and Wei Hao and Ruiling Zhang and Ying Zhao and Shi Wu Wen},
  journal={British Journal of Clinical Pharmacology},
  year={2021},
  volume={88},
  pages={2297 - 2305}
}
Hypothyroxinaemia might be easily ignored, because attention is typically paid to individuals with elevated thyroid stimulating hormone (TSH). In this study, we aimed to evaluate the association of oxcarbazepine use as adjuvant for treatment of schizophrenia with hypothyroxinaemia and central set point of thyroid homeostasis. 

References

SHOWING 1-10 OF 36 REFERENCES

A Case Series of Patients With Central Hypothyroidism From Oxcarbazepine Therapy

In the pediatric population, serum free thyroxine is reduced and thyroid-stimulating hormone concentrations are unchanged in patients taking oxcarbazepine with the mechanism thus being central hypothyroidism.

Antiepileptic drugs are associated with central hypothyroidism

The aim of this study was to search for CH in adults treated with AEDs and find whether the type of AED’s used matters, and to investigate the link between antiepileptic drugs and central hypothyroidism.

Thyroid Function in Girls with Epilepsy with Carbamazepine, Oxcarbazepine, or Valproate Monotherapy and after Withdrawal of Medication

Antiepileptic drugs may affect the serum thyroid hormone concentrations in girls taking carbamazepines, oxcarbazepine, or valproate monotherapy for epilepsy and after withdrawal of the treatment.

Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long‐term study

To evaluate prospectively the changes and possible associations in lipid and thyroid profiles in children treated with oxcarbazepine (OXC) monotherapy, a large number of patients with known and unknown medical conditions were treated with the drug.

Thyroid Function in Men Taking Carbamazepine, Oxcarbazepine, or Valproate for Epilepsy

Antiepileptic drugs (AEDs) may affect serum thyroid hormone concentrations and this study aimed to evaluate thyroid function in men taking carbamazepine, oxcarbazepines, or valproate for epilepsy.

The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index

A TSH index (TSHI) is proposed, as ‘fT4‐adjusted TSH’, that corrects for any physiological TSH suppression, to provide a true estimate of pituitary thyrotroph function and any pathological pituitaries suppression.

The Evaluation of Thyroid Functions, Thyroid Antibodies, and Thyroid Volumes in Children with Epilepsy during Short‐Term Administration of Oxcarbazepine and Valproate

The aim of this study was to evaluate the effects of short‐term oxcarbazepine and valproate monotherapy monotherapy on thyroid functions in children.

Hypothyroxinemia in critically ill patients as a predictor of high mortality.

There was a high correlation between low T4 levels and mortality and Hypothyroxinemia with normal thyroid-stimulating hormone levels was found in 22% of the patients.

Mirtazapine use may increase the risk of hypothyroxinemia in patients affected by major depressive disorder

Clinicians should be aware that hypothyroxinemia may be neglected in patients treated by mirtazapine due to attention paid only to those with elevated TSH, and patients affected by major depressive disorder should be warned of this risk.